Register for free
Recent Quotes
My Watchlist
Indicators
Business Insurance Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

(OP: POLBF )

0.1180 UNCHANGED
Last Price Updated: 3:19 PM EST, Nov 7, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about POLBF

Poolbeg Pharma's POLB 001 immuno-modulator II receives fully-granted patent from US Patent Office
Poolbeg Pharma's POLB 001 immuno-modulator II receives fully-granted patent from US Patent Office 
Via News Direct
Topics Intellectual Property
Exposures Intellectual Property
Poolbeg Pharma unveils new collaboration agreement
--News Direct-- 
Via News Direct
Poolbeg Pharma "moving forward rapidly" with POLB001
--News Direct-- 
Via News Direct
Topics Artificial Intelligence
Exposures Artificial Intelligence
Poolbeg Pharma and CytoReason identify "very exciting influenza targets"
Poolbeg Pharma and CytoReason identify "very exciting influenza targets" 
Via News Direct
Topics Artificial Intelligence
Exposures Artificial Intelligence
Poolbeg Pharma sees "significant commercial opportunity" in oral vaccines
Poolbeg Pharma sees "significant commercial opportunity" in oral vaccines 
Via News Direct
Poolbeg Pharma "in a very healthy cash position" after first full year of operations
Poolbeg Pharma "in a very healthy cash position" after first full year of operations 
Via News Direct
Proactive's Robin Davison publishes fresh research note on Poolbeg Pharma
Proactive's Robin Davison publishes fresh research note on Poolbeg Pharma 
Via News Direct
Poolbeg Pharma "couldn't be happier" with POLB 001 human challenge trial data
Poolbeg Pharma "couldn't be happier" with POLB 001 human challenge trial data 
Via News Direct
Poolbeg Pharma "really open" to different types of deal for POLB 001
Poolbeg Pharma "really open" to different types of deal for POLB 001 
Via News Direct
Poolbeg Pharma announces expansion of POLB 001 into oncology
Poolbeg Pharma announces expansion of POLB 001 into oncology 
Via News Direct
Topics Intellectual Property
Exposures Intellectual Property
Poolbeg Pharma upbeat on preliminary influenza drug results
Poolbeg Pharma upbeat on preliminary influenza drug results 
Via News Direct
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.
Register for free

Information

Copyright 2024. BUSINESS INSURANCE HOLDINGS